| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant effects of plasmid-generated hairpin RNA molecules on DNA vaccination
|
Li, Dingfeng
|
|
2007
|
25 |
39-40 |
p. 6992-7000
9 p.
|
article
|
| 2 |
An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh
|
Levin, Ann
|
|
2007
|
25 |
39-40 |
p. 6945-6957
13 p.
|
article
|
| 3 |
A sensitive cell-based assay for the detection of residual infectious West Nile virus
|
Koldijk, M.H.
|
|
2007
|
25 |
39-40 |
p. 6872-6881
10 p.
|
article
|
| 4 |
Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge
|
Bråve, Andreas
|
|
2007
|
25 |
39-40 |
p. 6882-6890
9 p.
|
article
|
| 5 |
Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas
|
Akporiaye, Emmanuel T.
|
|
2007
|
25 |
39-40 |
p. 6965-6974
10 p.
|
article
|
| 6 |
Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva
|
|
|
2007
|
25 |
39-40 |
p. 7006-
1 p.
|
article
|
| 7 |
Editorial Board/Aims and Scope
|
|
|
2007
|
25 |
39-40 |
p. CO2-
1 p.
|
article
|
| 8 |
Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with hepatitis B surface antigen-loaded elastic liposomes
|
Mishra, Dinesh
|
|
2007
|
25 |
39-40 |
p. 6939-6944
6 p.
|
article
|
| 9 |
Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda
|
Muganga, Narcisse
|
|
2007
|
25 |
39-40 |
p. 7001-7005
5 p.
|
article
|
| 10 |
Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years
|
Hammitt, Laura L.
|
|
2007
|
25 |
39-40 |
p. 6958-6964
7 p.
|
article
|
| 11 |
Influenza vaccine: The challenge of antigenic drift
|
Carrat, F.
|
|
2007
|
25 |
39-40 |
p. 6852-6862
11 p.
|
article
|
| 12 |
Inhibition effects on liver tumors of BALB/c mice bearing H22 cells by immunization with a recombinant immunogen of GnRH linked to heat shock protein 65
|
Zhang, Yin
|
|
2007
|
25 |
39-40 |
p. 6911-6921
11 p.
|
article
|
| 13 |
In vivo tissue distribution and kinetics of a pseudorabies virus plasmid DNA vaccine after intramuscular injection in swine
|
Gravier, Rodolphe
|
|
2007
|
25 |
39-40 |
p. 6930-6938
9 p.
|
article
|
| 14 |
Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine
|
Asanuma, Hideki
|
|
2007
|
25 |
39-40 |
p. 6975-6980
6 p.
|
article
|
| 15 |
Long lasting BCG protection against leprosy
|
Rodrigues, Laura Cunha
|
|
2007
|
25 |
39-40 |
p. 6842-6844
3 p.
|
article
|
| 16 |
Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein
|
Roy, Soumitra
|
|
2007
|
25 |
39-40 |
p. 6845-6851
7 p.
|
article
|
| 17 |
Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong
|
Ho, Pak-Leung
|
|
2007
|
25 |
39-40 |
p. 6837-6841
5 p.
|
article
|
| 18 |
Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses
|
Huang, Jun
|
|
2007
|
25 |
39-40 |
p. 6981-6991
11 p.
|
article
|
| 19 |
Quality control of routine, experimental and real-time aged diphtheria toxoids by in vitro analytical techniques
|
Metz, Bernard
|
|
2007
|
25 |
39-40 |
p. 6863-6871
9 p.
|
article
|
| 20 |
Re: Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5 year olds in New Zealand, Oster P, O’Hallahan J, Aaberge I, Tilman S, Ypma E, Martin D. Vaccine 2007;25(16):3075–9
|
Lennon, Diana
|
|
2007
|
25 |
39-40 |
p. 6835-
1 p.
|
article
|
| 21 |
Re: Safety review: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease, Nokleby H, Aavitsland P, O’Hallahan J, Feiring B, Tilman S, Oster P. Vaccine 2007;25(16):3080–4
|
Lennon, Diana
|
|
2007
|
25 |
39-40 |
p. 6833-
1 p.
|
article
|
| 22 |
Response to the Letter to the Editor written by Prof. Lennon (dated 27th April 2007) regarding the publication: “Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease” by Nøkleby H, Aavitsland P, O’Hallahan J, Feiring B, Tilman S, Oster P. (Vaccine 2007;25(16):3080–4)
|
Nøkleby, H.
|
|
2007
|
25 |
39-40 |
p. 6833-6834
2 p.
|
article
|
| 23 |
Response to the letter written by Professor Lennon (dated April 27, 2007) regarding our publication: “Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand” by Oster P, O’Hallahan J, Aaberge I, Tilman S, Ypma E, Martin D (Vaccine 2007;25(16):3075–79)
|
Oster, P.
|
|
2007
|
25 |
39-40 |
p. 6835-6836
2 p.
|
article
|
| 24 |
Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans
|
Etchart, Nathalie
|
|
2007
|
25 |
39-40 |
p. 6891-6899
9 p.
|
article
|
| 25 |
The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: A model-based analysis for Spain
|
Aballéa, Samuel
|
|
2007
|
25 |
39-40 |
p. 6900-6910
11 p.
|
article
|
| 26 |
The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach
|
Bos, J.M.
|
|
2007
|
25 |
39-40 |
p. 6922-6929
8 p.
|
article
|
Journal description